£2.0M
Anthemis Exponential Ventures led the seed round with participation from APEX Ventures and Entrepreneur First.
"The current pandemic vividly shows the need for digital, non-invasive technologies for clinical diagnosis and monitoring. Clinical trials are on hold, with regulators advising on the use of novel remote endpoints to salvage the trials. At the same time, the shift towards telemedicine models is further accelerating the adoption of digital technologies in the health care sectors. Novoic–with its next generation algorithms and strong focus on clinical validation–is best positioned to drive this acceleration."
